Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 8,061–8,080 of 17,964 drug recalls

Drug Recall Terminated Historical recordClass II

PAPAVERINE-PHENTOLAMINE-PGE1 17.44-0.64MG-5.8MCG/ML* INJECTABLE, 5 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Recall initiated
February 21, 2019
Reported by FDA
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

Drug Recall Terminated Historical recordClass II

PAPAVERINE-PHENTOLAMINE-PGE1 17.44-0.58MG-5.8MCG/ML* INJECTABLE, 5 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Recall initiated
February 21, 2019
Reported by FDA
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

Drug Recall Terminated Historical recordClass II

PAPAVERINE-PHENTOLAMINE-PGE1 15-0.25MG-6MCG/ML INJECTABLE, 5 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Recall initiated
February 21, 2019
Reported by FDA
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

Drug Recall Terminated Historical recordClass II

PAPAVERINE-PHENTOLAMINE-PGE1 30-1 MG-20 MCG/ML* INJECTABLE, 5 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Recall initiated
February 21, 2019
Reported by FDA
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

Drug Recall Terminated Historical recordClass II

PAPAVERINE-PHENTOLAMINE-PGE1 9-1 MG-10 MCG/ML* INJECTABLE, 18 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Recall initiated
February 21, 2019
Reported by FDA
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

Drug Recall Terminated Historical recordClass II

PAPAVERINE-PHENTOLAMINE-PGE1 22.5-0.8MG-8.3MCG/ML INJECTABLE, 5 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Recall initiated
February 21, 2019
Reported by FDA
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

Drug Recall Terminated Historical recordClass II

PAPAVERINE-PHENTOLAMINE-PGE1 17.64-0.58MG-5.88MCG/ML* INJECTABLE, 9 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Recall initiated
February 21, 2019
Reported by FDA
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

Drug Recall Terminated Historical recordClass II

PAPAVERINE-PHENTOLAMINE-PGE1 16.6-0.55 MG-11.1 MCG/ML* INJECTABLE, 10 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Recall initiated
February 21, 2019
Reported by FDA
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

Drug Recall Terminated Historical recordClass II

PAPAVERINE-PHENTOLAMINE-PGE1 15-0.5MG-10MCG/ML INJECTABLE, 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Recall initiated
February 21, 2019
Reported by FDA
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

Drug Recall Terminated Historical recordClass II

PAPAVERINE-PHENTOLAMINE-PGE1 30-2 MG-30 MCG/ML* INJECTABLE, 5ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Recall initiated
February 21, 2019
Reported by FDA
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

Drug Recall Terminated Historical recordClass II

PAPAVERINE-PHENTOLAMINE 30-0.5 MG/ML INJECTABLE, 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Recall initiated
February 21, 2019
Reported by FDA
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

Drug Recall Terminated Historical recordClass II

PAPAVERINE-PHENTOLAMINE 15-0.5MGMG/ML INJECTABLE, 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Recall initiated
February 21, 2019
Reported by FDA
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

Drug Recall Terminated Historical recordClass II

PGE1-LIDOCAINE 40 MCG-1% /ML* INJECTABLE, (a) 10 ml (b) 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Recall initiated
February 21, 2019
Reported by FDA
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

Drug Recall Terminated Historical recordClass II

PAPAVERINE-PHENTOLAMINE-PGE1 30-1.6 MG-16 MCG/ML* INJECTABLE, (a) 5ml, (b) 10ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Recall initiated
February 21, 2019
Reported by FDA
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

Drug Recall Terminated Historical recordClass II

PAPAVERINE-PHENTOLAMINE-PGE1 23-0.96MG-19.2MCG/ML INJECTABLE, (a) 5ml, (b) 6.5ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Recall initiated
February 21, 2019
Reported by FDA
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

Drug Recall Terminated Historical recordClass II

PAPAVERINE-PHENTOLAMINE-PGE1 17.16-0.57MG-19.45MCG/ML* INJECTABLE, 5ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Recall initiated
February 21, 2019
Reported by FDA
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

Drug Recall Terminated Historical recordClass II

PAPAVERINE-PHENTOLAMINE-PGE1 12-1MG-10MCG/ML INJECTABLE, (a) 10ml, (b) 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Recall initiated
February 21, 2019
Reported by FDA
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

Drug Recall Terminated Historical recordClass II

PAPAVERINE-PHENTOLAMINE-PGE1 30-1 MG-10 MCG/ML* INJECTABLE, (a) 5ml, (b) 6ml, (c) 9ml (d) 10ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Recall initiated
February 21, 2019
Reported by FDA
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

Drug Recall Terminated Historical recordClass II

PAPAVERINE-PHENTOLAMINE 30-1 MG/ML* INJECTABLE, (a)10ml (b) 9ml, penile injection, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Recall initiated
February 21, 2019
Reported by FDA
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

Drug Recall Terminated Historical recordClass II

PGE1 40 MCG/ML* INJECTABLE, (2) 5ml (b) 10ml, (c) 6ml (d) 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Reason
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Recall initiated
February 21, 2019
Reported by FDA
April 17, 2019
Distribution
Dispensed in Oregon

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.